TABLE 2.
Antibody specificity | Patients with DSA (n = 14) | Patients with non-DSA (n = 11) | P Value |
---|---|---|---|
Anti-HLA Class I | 1 (7%) | 5 (45%) | 0.06 |
Anti-HLA DR | 3 (21%) | 6 (55%) | 0.13 |
Anti-HLA DQ | 10 (71%) | 1 (9%) | 0.001 |
Anti-S | 9 (64%) | 11 (100%) | 0.16 |
Anti-S1 | 7 (50%) | 7 (64%) | 1 |
Anti-RBD | 7 (50%) | 11 (100%) | 0.03 |
Anti-S2 | 6 (43%) | 9 (82%) | 0.13 |
Anti-NC | 13 (93%) | 6 (55%) | 0.02 |
DSA, donor-specific anti-HLA antibody; S, trimeric spike protein; RBD, receptor binding domain; NC, nucleocapsid.